Published in PLoS One on May 18, 2010
Identification of amino acid residues important for heparan sulfate proteoglycan interaction within variable region 3 of the feline immunodeficiency virus surface glycoprotein. J Virol (2011) 0.85
Emergence of CD134 cysteine-rich domain 2 (CRD2)-independent strains of feline immunodeficiency virus (FIV) is associated with disease progression in naturally infected cats. Retrovirology (2014) 0.77
Mapping of Receptor Binding Interactions with the FIV surface Glycoprotein (SU); Implications Regarding Immune surveillance and cellular Targets of Infection. Retrovirology (Auckl) (2012) 0.77
Selective interaction of heparin with the variable region 3 within surface glycoprotein of laboratory-adapted feline immunodeficiency virus. PLoS One (2014) 0.76
Mutations in the feline immunodeficiency virus envelope glycoprotein confer resistance to a dominant-negative fragment of Tsg101 by enhancing infectivity and cell-to-cell virus transmission. Biochim Biophys Acta (2013) 0.76
Understanding the process of envelope glycoprotein incorporation into virions in simian and feline immunodeficiency viruses. Viruses (2014) 0.76
Replacement of the V3 domain in the surface subunit of the feline immunodeficiency virus envelope glycoprotein with the equivalent region of a T cell-tropic human immunodeficiency virus type 1 results in a chimeric surface protein that efficiently binds to CXCR4. AIDS Res Hum Retroviruses (2013) 0.76
Humoral Antibody Responses to HIV Viral Proteins and to CD4 Among HIV Controllers, Rapid and Typical Progressors in an HIV-Positive Patient Cohort. AIDS Res Hum Retroviruses (2016) 0.75
CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature (1996) 11.37
Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science (1991) 10.53
CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature (1996) 10.27
Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120. Proc Natl Acad Sci U S A (1988) 8.40
Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J Virol (1992) 7.92
Structure of a V3-containing HIV-1 gp120 core. Science (2005) 7.69
Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. Science (1990) 6.77
Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science (1987) 6.56
Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies. J Virol (1994) 3.43
V3: HIV's switch-hitter. AIDS Res Hum Retroviruses (2005) 3.00
Comparison of two host cell range variants of feline immunodeficiency virus. J Virol (1990) 2.98
Inhibition of human immunodeficiency virus fusion by a monoclonal antibody to a coreceptor (CXCR4) is both cell type and virus strain dependent. J Virol (1997) 2.42
Structural basis for coreceptor selectivity by the HIV type 1 V3 loop. AIDS Res Hum Retroviruses (2007) 2.19
Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses. J Virol (1997) 2.08
Use of CD134 as a primary receptor by the feline immunodeficiency virus. Science (2004) 1.93
Antigenically distinct conformations of CXCR4. J Virol (2001) 1.74
HIV-1 tropism and co-receptor use. Nature (1997) 1.60
Minimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors. J Virol (1999) 1.58
Binding of recombinant feline immunodeficiency virus surface glycoprotein to feline cells: role of CXCR4, cell-surface heparans, and an unidentified non-CXCR4 receptor. J Virol (2001) 1.54
Molecular mechanism of AMD3100 antagonism in the CXCR4 receptor: transfer of binding site to the CXCR3 receptor. J Biol Chem (2003) 1.50
Common mechanism of infection by lentiviruses. Nature (1997) 1.47
Structure and variations of feline immunodeficiency virus envelope glycoproteins. Virology (1993) 1.41
Structural descriptors of gp120 V3 loop for the prediction of HIV-1 coreceptor usage. PLoS Comput Biol (2007) 1.39
Feline immunodeficiency virus targets activated CD4+ T cells by using CD134 as a binding receptor. Proc Natl Acad Sci U S A (2004) 1.38
Identification of conserved and variable structures in the human immunodeficiency virus gp120 glycoprotein of importance for CXCR4 binding. J Virol (2002) 1.33
Effect of mutations in the second extracellular loop of CXCR4 on its utilization by human and feline immunodeficiency viruses. J Virol (1999) 1.31
Feline immunodeficiency virus (FIV) as a model for study of lentivirus infections: parallels with HIV. Curr HIV Res (2010) 1.29
Blocking of feline immunodeficiency virus infection by a monoclonal antibody to CD9 is via inhibition of virus release rather than interference with receptor binding. J Virol (1997) 1.21
Shared usage of the chemokine receptor CXCR4 by primary and laboratory-adapted strains of feline immunodeficiency virus. J Virol (1999) 1.20
The second extracellular loop of CXCR4 determines its function as a receptor for feline immunodeficiency virus. J Virol (1998) 1.19
Structural mapping of CD134 residues critical for interaction with feline immunodeficiency virus. Nat Struct Mol Biol (2004) 1.16
Isolation and partial characterization of infectious molecular clones of feline immunodeficiency virus obtained directly from bone marrow DNA of a naturally infected cat. J Virol (1992) 1.15
Conserved framework of envelope glycoproteins among lentiviruses. Curr Top Microbiol Immunol (1994) 1.15
Role of the amino-terminal extracellular domain of CXCR-4 in human immunodeficiency virus type 1 entry. Virology (1997) 1.15
Sequential CD134-CXCR4 interactions in feline immunodeficiency virus (FIV): soluble CD134 activates FIV Env for CXCR4-dependent entry and reveals a cryptic neutralization epitope. J Virol (2006) 1.08
Identification of conserved and variable regions in the envelope glycoprotein sequences of two feline immunodeficiency viruses isolated in Zurich, Switzerland. Virus Res (1991) 1.06
Factors that increase the effective concentration of CXCR4 dictate feline immunodeficiency virus tropism and kinetics of replication. J Virol (2004) 1.05
Molecular mechanisms of FIV infection. Vet Immunol Immunopathol (2008) 1.02
FIV infection of IL-2-dependent and -independent feline lymphocyte lines: host cells range distinctions and specific cytokine upregulation. Vet Immunol Immunopathol (1998) 0.98
Upregulation of surface feline CXCR4 expression following ectopic expression of CCR5: implications for studies of the cell tropism of feline immunodeficiency virus. J Virol (2002) 0.91
Advances in FIV vaccine technology. Vet Immunol Immunopathol (2008) 0.91
Mutations at the CXCR4 interaction sites for AMD3100 influence anti-CXCR4 antibody binding and HIV-1 entry. FEBS Lett (2003) 0.90
Chemokine receptors and co-stimulatory molecules: unravelling feline immunodeficiency virus infection. Vet Immunol Immunopathol (2008) 0.89
Mapping of the CXCR4 binding site within variable region 3 of the feline immunodeficiency virus surface glycoprotein. J Virol (2008) 0.89
Feline immunodeficiency virus OrfA alters gene expression of splicing factors and proteasome-ubiquitination proteins. Virology (2007) 0.88
Role of HIV-1 subtype C envelope V3 to V5 regions in viral entry, coreceptor utilization and replication efficiency in primary T-lymphocytes and monocyte-derived macrophages. Virol J (2007) 0.85
The N-terminal of the V3 loop in HIV type 1 gp120 is responsible for its conformation-dependent interaction with cell surface molecules. AIDS Res Hum Retroviruses (2004) 0.80
Animal models of retroviral encephalopathies: feline model. Curr Protoc Neurosci (2002) 0.79
From the Cover: Directed, efficient, and versatile modifications of the Drosophila genome by genomic engineering. Proc Natl Acad Sci U S A (2009) 3.17
Crumbs regulates Salvador/Warts/Hippo signaling in Drosophila via the FERM-domain protein Expanded. Curr Biol (2010) 3.08
The apical transmembrane protein Crumbs functions as a tumor suppressor that regulates Hippo signaling by binding to Expanded. Proc Natl Acad Sci U S A (2010) 2.43
Efficient ends-out gene targeting in Drosophila. Genetics (2008) 1.74
Inhibitors of HIV-1 protease by using in situ click chemistry. Angew Chem Int Ed Engl (2006) 1.63
The histone deacetylase inhibitor LBH589 enhances the anti-myeloma effects of chemotherapy in vitro and in vivo. Leuk Res (2010) 1.59
The Caenorhabditis elegans heterochronic regulator LIN-14 is a novel transcription factor that controls the developmental timing of transcription from the insulin/insulin-like growth factor gene ins-33 by direct DNA binding. Mol Cell Biol (2005) 1.44
Feline immunodeficiency virus targets activated CD4+ T cells by using CD134 as a binding receptor. Proc Natl Acad Sci U S A (2004) 1.38
Conformational flexibility in the flap domains of ligand-free HIV protease. Acta Crystallogr D Biol Crystallogr (2007) 1.36
Feline immunodeficiency virus (FIV) as a model for study of lentivirus infections: parallels with HIV. Curr HIV Res (2010) 1.29
1,2,3-triazole as a peptide surrogate in the rapid synthesis of HIV-1 protease inhibitors. Chembiochem (2005) 1.27
A highly conserved arginine in gp120 governs HIV-1 binding to both syndecans and CCR5 via sulfated motifs. J Biol Chem (2005) 1.23
An Improved Cloud Classification Algorithm for China's FY-2C Multi-Channel Images Using Artificial Neural Network. Sensors (Basel) (2009) 1.21
Structural mapping of CD134 residues critical for interaction with feline immunodeficiency virus. Nat Struct Mol Biol (2004) 1.16
Is resistance futile? Curr Drug Targets Infect Disord (2003) 1.14
Characterization of a highly pathogenic molecular clone of feline immunodeficiency virus clade C. J Virol (2004) 1.14
Rapid diversity-oriented synthesis in microtiter plates for in situ screening of HIV protease inhibitors. Chembiochem (2003) 1.13
Changes to the HIV long terminal repeat and to HIV integrase differentially impact HIV integrase assembly, activity, and the binding of strand transfer inhibitors. J Biol Chem (2007) 1.13
Dual Roles of Helicobacter pylori NapA in inducing and combating oxidative stress. Infect Immun (2006) 1.11
Robust expression of a bioactive mammalian protein in Chlamydomonas chloroplast. Plant Biotechnol J (2007) 1.09
Targeted engineering of the Drosophila genome. Fly (Austin) (2009) 1.09
Inhibition of HIV Env binding to cellular receptors by monoclonal antibody 2G12 as probed by Fc-tagged gp120. Retrovirology (2006) 1.08
Sequential CD134-CXCR4 interactions in feline immunodeficiency virus (FIV): soluble CD134 activates FIV Env for CXCR4-dependent entry and reveals a cryptic neutralization epitope. J Virol (2006) 1.08
Specific interaction of feline immunodeficiency virus surface glycoprotein with human DC-SIGN. J Virol (2004) 1.07
Characterization of de qi with electroacupuncture at acupoints with different properties. J Altern Complement Med (2011) 1.06
Factors that increase the effective concentration of CXCR4 dictate feline immunodeficiency virus tropism and kinetics of replication. J Virol (2004) 1.05
Successive and targeted DNA integrations in the Drosophila genome by Bxb1 and phiC31 integrases. Genetics (2011) 1.02
Molecular mechanisms of FIV infection. Vet Immunol Immunopathol (2008) 1.02
[Electroacupuncture at Guanyuan (CV 4) and Zhongwan (CV 12) modulates functional connectivity of the brain network in healthy volunteers]. Zhen Ci Yan Jiu (2011) 1.01
Effects of Bafilomycin A1: an inhibitor of vacuolar H (+)-ATPases on endocytosis and apoptosis in RAW cells and RAW cell-derived osteoclasts. J Cell Biochem (2003) 1.01
Feline immunodeficiency virus OrfA is distinct from other lentivirus transactivators. J Virol (2002) 1.00
Human immunodeficiency virus type 1 and influenza virus exit via different membrane microdomains. J Virol (2007) 1.00
Differential regulation of adherens junction dynamics during apical-basal polarization. J Cell Sci (2011) 1.00
Study on differences in the pathology, T cell subsets and gene expression in susceptible and non-susceptible hosts infected with Schistosoma japonicum. PLoS One (2010) 0.98
Unique long terminal repeat and surface glycoprotein gene sequences of feline leukemia virus as determinants of disease outcome. J Virol (2005) 0.98
MiR-320a down-regulation mediates bladder carcinoma invasion by targeting ITGB3. Mol Biol Rep (2014) 0.97
Assessment of FIV-C infection of cats as a function of treatment with the protease inhibitor, TL-3. Retrovirology (2004) 0.97
Structural basis for distinctions between substrate and inhibitor specificities for feline immunodeficiency virus and human immunodeficiency virus proteases. J Virol (2003) 0.97
Apoptosis governs the elimination of Schistosoma japonicum from the non-permissive host Microtus fortis. PLoS One (2011) 0.96
Reliability and validity of the GMFM-66 in 0- to 3-year-old children with cerebral palsy. Am J Phys Med Rehabil (2006) 0.95
Small molecule regulation of protein conformation by binding in the Flap of HIV protease. ACS Chem Biol (2013) 0.94
MiR-21 up-regulation mediates glioblastoma cancer stem cells apoptosis and proliferation by targeting FASLG. Mol Biol Rep (2014) 0.94
Replication properties of clade A/C chimeric feline immunodeficiency viruses and evaluation of infection kinetics in the domestic cat. J Virol (2008) 0.94
Structural insights into the mechanisms of drug resistance in HIV-1 protease NL4-3. J Mol Biol (2005) 0.93
A copper(I)-catalyzed 1,2,3-triazole azide-alkyne click compound is a potent inhibitor of a multidrug-resistant HIV-1 protease variant. J Med Chem (2008) 0.92
Lipid peroxidation as a source of oxidative damage in Helicobacter pylori: protective roles of peroxiredoxins. Biochim Biophys Acta (2006) 0.92
Defining HIV-1 protease substrate selectivity. Curr Drug Targets Infect Disord (2002) 0.91
Antimyeloma effects of arsenic trioxide are enhanced by melphalan, bortezomib and ascorbic acid. Br J Haematol (2007) 0.89
Comparison of worm development and host immune responses in natural hosts of Schistosoma japonicum, yellow cattle and water buffalo. BMC Vet Res (2012) 0.89
W::Neo: a novel dual-selection marker for high efficiency gene targeting in Drosophila. PLoS One (2012) 0.89
Pd(II)-catalyzed C-H iodination using molecular I2 as the sole oxidant. J Am Chem Soc (2013) 0.89
Mapping of the CXCR4 binding site within variable region 3 of the feline immunodeficiency virus surface glycoprotein. J Virol (2008) 0.89
Crystallographic fragment-based drug discovery: use of a brominated fragment library targeting HIV protease. Chem Biol Drug Des (2013) 0.88
Feline immunodeficiency virus OrfA alters gene expression of splicing factors and proteasome-ubiquitination proteins. Virology (2007) 0.88
Resolution and prevention of feline immunodeficiency virus-induced neurological deficits by treatment with the protease inhibitor TL-3. J Virol (2004) 0.87
MicroRNA expression profile in different tissues of BALB/c mice in the early phase of Schistosoma japonicum infection. Mol Biochem Parasitol (2013) 0.87
Crystal structure of an FIV/HIV chimeric protease complexed with the broad-based inhibitor, TL-3. Retrovirology (2007) 0.87
Altered gag polyprotein cleavage specificity of feline immunodeficiency virus/human immunodeficiency virus mutant proteases as demonstrated in a cell-based expression system. J Virol (2006) 0.87
Identification of broad-based HIV-1 protease inhibitors from combinatorial libraries. Biochem J (2010) 0.87
Differential gene expression in Schistosoma japonicum schistosomula from Wistar rats and BALB/c mice. Parasit Vectors (2011) 0.86
White matter abnormalities in major depression: a tract-based spatial statistics and rumination study. PLoS One (2012) 0.86
The proteasome inhibitor CEP-18770 enhances the anti-myeloma activity of bortezomib and melphalan. Br J Haematol (2009) 0.86
Sertraline protects against monocrotaline-induced pulmonary hypertension in rats. Clin Exp Pharmacol Physiol (2006) 0.85
Identification of amino acid residues important for heparan sulfate proteoglycan interaction within variable region 3 of the feline immunodeficiency virus surface glycoprotein. J Virol (2011) 0.85
Ultrastructural observation and gene expression profiling of Schistosoma japonicum derived from two natural reservoir hosts, water buffalo and yellow cattle. PLoS One (2012) 0.85
Proteomic analysis of tegument-exposed proteins of female and male Schistosoma japonicum worms. J Proteome Res (2013) 0.84
Comparison of the differential expression miRNAs in Wistar rats before and 10 days after S.japonicum infection. Parasit Vectors (2013) 0.84
The Limbic-Prefrontal Network Modulated by Electroacupuncture at CV4 and CV12. Evid Based Complement Alternat Med (2012) 0.84
Molecular cloning and characterization of a gene encoding methionine aminopeptidase 2 of Schistosoma japonicum. Parasitol Res (2010) 0.83
Loss of protein kinase C-δ protects against LPS-induced osteolysis owing to an intrinsic defect in osteoclastic bone resorption. PLoS One (2013) 0.83
LAGlambda-1: a clinically relevant drug resistant human multiple myeloma tumor murine model that enables rapid evaluation of treatments for multiple myeloma. Int J Oncol (2006) 0.83
Drosophila Patj plays a supporting role in apical-basal polarity but is essential for viability. Development (2012) 0.83
Repaglinide-gemfibrozil drug interaction: inhibition of repaglinide glucuronidation as a potential additional contributing mechanism. Br J Clin Pharmacol (2010) 0.83
Characterization of thioredoxin glutathione reductase in Schiotosoma japonicum. Parasitol Int (2012) 0.82
Apoptosis phenomenon in the schistosomulum and adult worm life cycle stages of Schistosoma japonicum. Parasitol Int (2012) 0.82
Molecular characterization of thyroid hormone receptor beta from Schistosoma japonicum and assessment of its potential as a vaccine candidate antigen against schistosomiasis in BALB/c mice. Parasit Vectors (2012) 0.82
Generation of infectious feline immunodeficiency virus (FIV) encoding FIV/human immunodeficiency virus chimeric protease. J Virol (2010) 0.81
Pathogenicity and rapid growth kinetics of feline immunodeficiency virus are linked to 3' elements. PLoS One (2011) 0.81
Transporter studies with the 3-O-sulfate conjugate of 17alpha-ethinylestradiol: assessment of human kidney drug transporters. Drug Metab Dispos (2010) 0.80
Molecular cloning and characterization of a cyclophilin A homologue from Schistosoma japonicum. Parasitol Res (2012) 0.80
Nicotine prevents HIVgp120-caused electrophysiological and motor disturbances in rats. Neurosci Lett (2005) 0.80
Early detection of neuropathophysiology using diffusion-weighted magnetic resonance imaging in asymptomatic cats with feline immunodeficiency viral infection. J Neurovirol (2011) 0.80
OrfA downregulates feline immunodeficiency virus primary receptor CD134 on the host cell surface and is important in viral infection. J Virol (2010) 0.80
Design and synthesis of broad-based mono- and bi- cyclic inhibitors of FIV and HIV proteases. Bioorg Med Chem (2003) 0.80
Development of a hyena immunology toolbox. Vet Immunol Immunopathol (2011) 0.80
Influence of the MACC1 gene on sensitivity to chemotherapy in human U251 glioblastoma cells. Asian Pac J Cancer Prev (2015) 0.80
Construction of artificial laminae of the vertebral arch using bone marrow mesenchymal stem cells transplanted in collagen sponge. Spine (Phila Pa 1976) (2012) 0.79
Cloning, expression and characterization of protein disulfide isomerase of Schistosoma japonicum. Exp Parasitol (2014) 0.79
Cloning, expression, and characterization of Schistosoma japonicum tegument protein phosphodiesterase-5. Parasitol Res (2011) 0.79
Improved health and survival of FIV-infected cats is associated with the presence of autoantibodies to the primary receptor, CD134. Proc Natl Acad Sci U S A (2009) 0.79
CEP-18770 (delanzomib) in combination with dexamethasone and lenalidomide inhibits the growth of multiple myeloma. Leuk Res (2012) 0.79
Involvement of calmodulin and actin in directed differentiation of rat cortical neural stem cells into neurons. Int J Mol Med (2011) 0.79